Turning Cost Challenges into Quality Solutions: Key Takeaways from Embold’s 2026 Client Advisory Board

Embold Health’s 2026 Client Advisory Board convened in New Orleans on April 21, 2026, with a clear objective: address one of the most persistent challenges in healthcare today, rising costs driven by variation in care quality.  

Defining the Problem Up Front

The day began not with presentations, but with perspective. Attendees were asked to share the most pressing challenges facing their organizations, and a consistent theme quickly emerged: the trend problem continues to dominate.

Employers and health plans are under pressure to control rising costs, but not at the expense of member outcomes. The challenge is more nuanced and focuses on how employers can lower spend while actively steering members toward higher-quality providers. This tension set the stage for the conversations that followed.

‍

Progress Made, Problem Still Standing

Embold Health’s President & Founder, Daniel Stein, MD, MBA, opened the session by reflecting on Embold’s progress over the past year and outlining the path forward. Over the last 12 months, the organization has expanded clinical measurement across specialties, emphasized the interdependency between quality and cost, and scaled guidance to reach members at the moment decisions are made. Millions of members are now supported through these efforts.  

At the same time, the underlying issue remains unchanged. Variation in care quality continues to drive unnecessary costs across the system. The same diagnosis, treated by different providers, can result in significantly different outcomes and total spend.  

The implication is clear: what appears to be a cost problem is fundamentally a quality problem.

Making Quality Actionable

A central theme of the day was how measurement is evolving to better support real-world decisions. Historically, provider performance has been evaluated at a broad level, enabling population insights and general navigation. While effective, this approach does not fully address the specificity of individual care decisions.

Healthcare decisions are situational. Members are often looking for the best provider for a particular procedure, condition, or episode of care.

To meet this need, Embold introduced enhancements to its measurement framework, including episode-based cost analysis and subspecialty domain scoring. These advancements connect cost and quality to specific clinical scenarios, allowing for more precise provider comparisons and more relevant guidance.  

This shift moves measurement from being informative to being directly actionable at the point of decision.

‍

From Insight to Experience

Attendees were given a closer look at how quality advancements translate into real solutions through product demonstrations, highlighting the connection between Embold’s evolving analytics and measurement capabilities, its forward-looking product roadmap, and how these come together to deliver real-time, personalized guidance for members.

The Embold product roadmap reflects a focused effort to translate quality intelligence into real-time, personalized member experiences. Central to this strategy is continued investment in AI-driven orchestration, enabling guidance that not only informs decisions but actively shapes how members navigate care.

Recent progress includes scaling AI-powered navigation to millions of members and introducing Embold Edge, the first national quality-driven health plan designed to help employers and health plans reduce healthcare costs by addressing variation in clinical quality. The model brings together analytics, navigation, benefit design, and incentives into a more unified experience.

Looking ahead, Embold is advancing several strategic capabilities:

• More proactive, personalized guidance informed by real-time member context  

• Deeper integration across the care ecosystem, including virtual care, scheduling, and Centers of Excellence  

• Greater cost transparency through more precise, member-specific estimates  

• A more advanced decisioning infrastructure to support timely, high-value care decisions  

At the center of this approach is Embold’s Intelligence & Decisioning Engine, which serves as the connective layer across data, clinical insights, and partner solutions. By synthesizing these inputs, the platform delivers clear, personalized recommendations that guide members toward higher-value care.

Together, these advancements reflect a broader shift from insight generation to execution, embedding quality directly into the decisions that drive outcomes and cost at scale.

‍

Reframing the Approach Together

Through structured breakout sessions, participants explored critical topics including plan design, member experience, data transparency, and ecosystem partnerships.

The focus was not on incremental change, but on identifying where new approaches could meaningfully shift outcomes. Groups examined existing barriers, challenged long-held assumptions, and surfaced alternative strategies to address them.

This exchange of ideas reinforced the importance of cross-functional collaboration in tackling complex healthcare challenges.

A Clear Direction Forward

The discussions throughout the 2026 Client Advisory Board pointed to a consistent conclusion: sustainable cost reduction requires a deeper focus on quality. Not as a secondary consideration, but as the foundation for decision-making, benefit design, and member engagement.

As Embold continues to advance its solutions, including enhanced measurement, AI-driven navigation, and integrated plan design, the emphasis on quality remains central.

The insights shared in New Orleans will play a critical role in shaping what comes next. With continued collaboration and a shared commitment to better care, the path forward becomes not only clearer, but more achievable.

‍

‍Discover how Embold Health is transforming care. Download the e-book today.